Journal of the National Cancer Institute (JNCI) |
Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer |
mai. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Journal of the National Cancer Institute (JNCI) |
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study |
juil. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial |
nov. 15 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors |
mar. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. |
sep. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States |
déc. 18 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of the National Cancer Institute (JNCI) |
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer |
mai. 17 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas |
Jan. 17 |
|
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis |
aoû. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Sweetened Beverage Consumption and Risk of Biliary Tract and Gallbladder Cancer in a Prospective Study |
juin. 16 |
2 ♥ |
Cancers autres |
Journal of the National Cancer Institute (JNCI) |
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer |
aoû. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab |
oct. 16 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP) |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies |
mar. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Long-term outcomes of patients with 10 or more colorectal liver metastases |
aoû. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma |
Jan. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer |
Jan. 17 |
2 ♥ |
Cancer colorectal |
British journal of Cancer |
A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer |
juin. 16 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2) |
sep. 15 |
2 ♥ |
Cancers autres (hors CCR et CHC), Œsophage/Estomac |
British journal of Cancer |
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
A phase 2 randomised study of veliparib plus FOLFIRI ± bevacizumab versus placebo plus FOLFIRI ± bevacizumab in metastatic colorectal cancer |
Jan. 19 |
1 ♥ |
Cancer colorectal (CCR) |